LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 4 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 1. - Dataset (ID:20312)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.10 | 770.96 | 1388 | 3605 | 0.3857 | 0.3025 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.40 | 770.96 | 1413 | 3985 | 0.3551 | 0.2912 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.60 | 770.96 | 1425 | 4421 | 0.3227 | 0.2756 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 40.80 | 770.96 | 1448 | 4874 | 0.2976 | 0.2671 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 43.00 | 770.96 | 1469 | 5280 | 0.2785 | 0.2609 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 45.30 | 770.96 | 1473 | 5677 | 0.2598 | 0.2517 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 47.50 | 770.96 | 1496 | 6082 | 0.2462 | 0.2487 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 49.70 | 770.96 | 1512 | 6511 | 0.2324 | 0.2441 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.90 | 770.96 | 1527 | 6944 | 0.2200 | 0.2398 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 54.10 | 770.96 | 1522 | 7405 | 0.2056 | 0.2311 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 56.40 | 770.96 | 1548 | 7845 | 0.1974 | 0.2311 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.60 | 770.96 | 1558 | 8264 | 0.1886 | 0.2278 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 60.80 | 770.96 | 1568 | 8711 | 0.1801 | 0.2246 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.00 | 770.96 | 1594 | 9152 | 0.1742 | 0.2253 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.30 | 770.96 | 1600 | 9591 | 0.1668 | 0.2219 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.50 | 770.96 | 1622 | 9939 | 0.1632 | 0.2229 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.70 | 770.96 | 1628 | 10312 | 0.1579 | 0.2207 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.90 | 770.96 | 1636 | 10631 | 0.1539 | 0.2194 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.10 | 770.96 | 1635 | 10921 | 0.1498 | 0.2164 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.40 | 770.96 | 1639 | 11184 | 0.1465 | 0.2150 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.60 | 770.96 | 1655 | 11443 | 0.1446 | 0.2158 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.80 | 770.96 | 1656 | 11725 | 0.1413 | 0.2139 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 83.10 | 770.96 | 1664 | 12002 | 0.1387 | 0.2131 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 85.30 | 770.96 | 1663 | 12277 | 0.1355 | 0.2110 |
MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.50 | 770.96 | 1665 | 12567 | 0.1325 | 0.2091 |